Neoadjuvant Therapy for Gastric Cancer (Q57845991)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Neoadjuvant therapy for gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Michael G House

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

151-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Gastric cancer treatment guidelines in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Cancer of the stomach. A patient care study by the American College of Surgeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Does Graded Histologic Response After Neoadjuvant Chemotherapy Predict Survival for Completely Resected Gastric Cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Value of palliative resection in gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Laparoscopy in the management of gastric adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Usefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Patterns of initial recurrence in completely resected gastric adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Genomic signatures to guide the use of chemotherapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

A pilot study of preoperative chemoradiotherapy for resectable gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Extended lymph-node dissection for gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Should systematic lymph node dissection be recommended for gastric cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Effect of microscopic resection line disease on gastric cancer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

Prospective randomized trial of combined oncological therapy for gastric carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YASU.2008.04.003

10.1016/J.YASU.2008.04.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18953815%20AND%20SRC:MED&resulttype=core&format=json